KDT Venture Capital (KDTVC) is an investment firm that specializes in providing capital and support to innovative startups and emerging companies. The firm focuses on early-stage investments and aims to foster growth and development in its portfolio companies.

KDT Venture Capital

KdT Ventures is a new age seed stage venture firm, with a focus on the intersection of technology and science. Our thesis is that advances in compute are allowing us to solve problems never before addressable. Our goal is to help entrepreneurs turn their own ideas and visions into successful, impactful companies.

Circularis Biotechnologies

Azitra

Bienville Capital

KdT Ventures

the founding thesis of Terray Therapeutics was that the biggest bottleneck in AI-driven drug discovery is a paucity of high-quality data at scale. five years in, Terray has built an end-to-end platform that integrates automated chemical experimentation and generative AI, all purpose-built with the end (generating safe, effective, drug-like small molecules) in mind. 

excited to announce a collaboration and investment in Terray from NVentures, NVIDIA's venture arm. Terray and NVIDIA will collaborate on completing SOTA chemistry foundation models, some of which will be made available on NVIDIA's BioNeMo platform for AI in drug discovery. by open-sourcing some of Terray's models, the drug discovery community will see what we see: the "unreasonable effectiveness" of high-quality experimental data in solving complex problems in drug discovery.

full press release: https://lnkd.in/e-GkiUCd

Eli Berlin Jacob Berlin, PhD Narbe Mardirossian

Today at #ESGCT2023 we were excited to announce the launch of our Dyno eCap™ 1 capsid, a field-leading AAV capsid for eye gene therapies 👁🧬. This vector transduces clinically-relevant cell types across the retina and outperforms both AAV2 and external engineered capsids in NHP experiments.

Learn more about this breakthrough capsid at https://lnkd.in/eAeDC-vJ and contact bd@dynotx.com about licensing opportunities.

COM:KDTVC

KDT Venture Capital